| A Clinical Study of FT1 in Patients With Short Bowel Syndrome (NCT07704047) | Chongqing Peg-Bio Biopharm Co., Ltd. | 2026-08-30 |
| A Multicenter, Single Arm Study to Evaluate the Preliminary Efficacy and Safety Profile of Inavolisib in Previously Treated Pancreatic Ductal Adenocarcinoma Patients (NCT07694973) | Fudan University | 2026-08-29 |
| A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer (NCT07693751) | SOTIO Biotech a.s. | 2026-08-29 |
| Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) (NCT07072585) | Children's Oncology Group | 2026-08-28 |
| Culmerciclib Plus Anlotinib and Endocrine Therapy for HR-Positive/HER2-Negative Metastatic Breast Cancer With Brain Metastases (NCT07745257) | Sun Yat-sen University | 2026-08-28 |
| AK112 Combined With GAP Conversion Therapy for Locally Advanced Gallbladder Cancer (NCT07767994) | First Affiliated Hospital Xi'an Jiaotong University | 2026-08-28 |
| A Study of AC-101 Tablets in Patients With Ulcerative Colitis (NCT07755241) | Accro Bioscience (Suzhou) Limited | 2026-08-28 |
| Phase II Study of the Combination of Subcutaneous Blinatumomab and Olverembatinib in Patients With Philadelphia Chromosome (ph)-Positive and/or BCR::ABL1 Positive Acute Lymphoblastic Leukemia (ALL) (NCT07178912) | M.D. Anderson Cancer Center | 2026-08-27 |
| Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma (NCT06319196) | University Health Network, Toronto | 2026-08-27 |
| A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease (NCT07737743) | Novartis Pharmaceuticals | 2026-08-27 |
| A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes (NCT07357740) | Novo Nordisk A/S | 2026-08-27 |
| Periganglionic Resiniferatoxin for the Treatment of Intractable Pain Due to Cancer-induced Bone Pain (NCT02522611) | National Institute of Neurological Disorders and Stroke (NINDS) | 2026-08-27 |
| Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse (NCT06948084) | National Cancer Institute (NCI) | 2026-08-26 |
| DAREON®-36: A Study to Test Obrixtamig in Combination With ZL-1310 in People With Advanced Small Cell Lung Cancer or Other Neuroendocrine Cancers (NCT07707895) | Boehringer Ingelheim | 2026-08-26 |
| A Phase 2b Trial of Lesion Network Mapping-Guided cTBS for Motor Recovery After Acute Ischemic Stroke (NCT07645560) | Beijing Tiantan Hospital | 2026-08-26 |
| Evaluating the Efficacy and Safety of of HSK50042 in People With Idiopathic Pulmonary Fibrosis (NCT07728721) | Haisco Pharmaceutical Group Co., Ltd. | 2026-08-25 |
| Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis (NCT06609343) | The University of Texas Health Science Center at San Antonio | 2026-08-24 |
| Caring Recharge Project for Caregivers of Individuals With Alzheimer's Disease (NCT07764185) | Photozig, Inc. | 2026-08-24 |
| Combination Therapy (Mirdametinib and Sirolimus) for RAS Mutated Relapsed Refractory Multiple Myeloma (NCT06876142) | National Cancer Institute (NCI) | 2026-08-23 |
| IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy (NCT07686380) | National Cancer Institute (NCI) | 2026-08-23 |
| Combination Bevacizumab and PRGN-2012 in Adults With Recurrent Respiratory Papillomatosis (RRP) (NCT07756840) | National Cancer Institute (NCI) | 2026-08-23 |
| Penpulimab Combined With Chemotherapy for Patients With Locally Advanced Hypopharyngeal Carcinoma (NCT07752394) | Tang-Du Hospital | 2026-08-23 |
| Pacritinib, a Kinase Inhibitor of CSF1R, IRAK1, JAK2, and FLT3, in Adults and Pediatric Participants 12 Years of Age or Older With Myelodysplastic Syndromes or Myelodysplastic/Myeloproliferative Neoplasms (NCT06303193) | National Cancer Institute (NCI) | 2026-08-23 |
| Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance (NCT07574541) | National Cancer Institute (NCI) | 2026-08-23 |
| A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity (NCT06406465) | National Cancer Institute (NCI) | 2026-08-23 |
| Neoadjuvant Inhaled Azacytidine With Platinum-Based Chemotherapy and Durvalumab (MEDI4736) - a Combined Epigenetic-Immunotherapy (AZA-AEGEAN) Regimen for Operable Early-Stage Non-Small Cell Lung Cancer (NSCLC) (NCT06694454) | National Cancer Institute (NCI) | 2026-08-23 |
| Investigating the Analgesic Potential of (2R,6R)-HNK in Acute Pain in Healthy Volunteers (NCT07504601) | National Center for Complementary and Integrative Health (NCCIH) | 2026-08-23 |
| Effects of Meal Macronutrients on Postprandial Lipids (NCT07313787) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-08-23 |
| Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate Cancer (NCT07667400) | National Cancer Institute (NCI) | 2026-08-23 |
| An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental Glomerulosclerosis (NCT06664814) | National Human Genome Research Institute (NHGRI) | 2026-08-23 |
| FAST for DM - Fatty Acid Supplementation Trial (FAST) for Dermatomyositis (DM) (NCT07111065) | National Institute of Environmental Health Sciences (NIEHS) | 2026-08-23 |
| Stem Cell Transplantation for Participants With Germline RUNX1 Associated Blood Cancers (NCT07524530) | National Cancer Institute (NCI) | 2026-08-23 |
| Trial of the Combination of Alpha-Lipoic Acid and Mirabegron in Women and in Men With Obesity (NCT05713799) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-08-23 |
| FATIMA Trial: EGCG and Vitamin D3 for Prevention of Fibroid Recurrence (NCT07647198) | Sheikh Shakhbout Medical City | 2026-08-22 |
| Bevonescein for Improved Intraoperative Nerve Visualization to Improve Voice Outcomes in Thyroidectomy Patients (NCT07631650) | Matthew Spector | 2026-08-21 |
| Testing the Safety and Feasibility of Immunotherapy Drugs, Botensilimab and Balstilimab, Before Surgery for Clear Cell Renal Cell Carcinoma, NEO RoBOT Trial (NCT07516366) | National Cancer Institute (NCI) | 2026-08-21 |
| A Clinical Trial of MK-1045 in People With B-cell Cancer (MK-1045-006) (NCT07709000) | Merck Sharp & Dohme LLC | 2026-08-21 |
| Phase II Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of ALK201 for Injection in Combination With Ivonescimab Injection in sqNSCLC Participants. (NCT07742956) | Shanghai Allink Biotherapeutics Co., Ltd. | 2026-08-20 |
| Effect of Height Based vs Conventional Dose of Spinal Anesthesia in Lower Limb Surgeries (NCT07751835) | Liaquat National Hospital & Medical College | 2026-08-20 |
| Assessing the Efficacy of a High-Dose Lidocaine-Tetracaine Cream for the Treatment of Peripheral Neuropathic Pain (NCT07396129) | Pontificia Universidad Catolica de Chile | 2026-08-20 |
| An Exploratory Clinical Study of Accurate Efficacy Assessment of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on 68Ga-FAPI ([68Ga] Fibroblast Activation Protein Inhibitor)/¹⁸F-FDG (2-Deoxy-2-[¹⁸F]Fluoro-D-glucose) Dual Imaging (NCT07770672) | Tan Lijie | 2026-08-20 |
| Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression (NCT07715279) | West China Hospital | 2026-08-20 |
| First-in-Human Trial of VBC106 in Participants With Advanced Solid Tumors (NCT07686068) | VelaVigo Bio Inc | 2026-08-18 |
| A Pilot Study of an Antioxidant Cocktail vs. Placebo in the Treatment of Children and Adolescents With Rett Syndrome (NCT04041713) | Holland Bloorview Kids Rehabilitation Hospital | 2026-08-17 |
| A Phase II Study to Evaluate JMKX000197 Injection Versus Cisplatin in the Treatment of Malignant Pleural Effusion (NCT07649369) | Shanghai Jeyou Pharmaceutical Co., Ltd. | 2026-08-17 |
| Safety and Efficacy Study of Sivelestat in Neuromyelitis Optica Spectrum Disorder (NCT07738952) | Kyushu University | 2026-08-17 |
| Feasibility of Fluorescence Imaging With Bevacizumab-800CW During Bronchoscopy (NCT06809946) | University Medical Center Groningen | 2026-08-17 |
| Temozolomide, With or Without WSD0922-FU, for the Treatment of EGFR-Mutant, IDH-Wildtype Glioblastoma (NCT07708961) | Mayo Clinic | 2026-08-16 |
| One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis (NCT06367361) | Universidad Peruana Cayetano Heredia | 2026-08-15 |
| Neoadjuvant Pucotenlimab and Becotatug Vedotin for Locally Advanced Penile Cancer (NCT07767266) | Sun Yat-sen University | 2026-08-15 |
| Golidocitinib Plus Anthracycline-based Therapy for Untreated Nodal T-follicular Helper (TFH) Cell Lymphoma (NCT07753642) | Sun Yat-sen University | 2026-08-15 |
| SABR Combined With Axitinib and Toripalimab for Oligometastatic Renal Cell Carcinoma (NCT07744932) | Hebei Medical University Fourth Hospital | 2026-08-15 |
| A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT07680764) | Bristol-Myers Squibb | 2026-08-15 |
| High-energy Human Milk Diets in the First Two Weeks After Birth to Reduce BPD in Extremely Preterm Infants (NCT07307612) | University of Alabama at Birmingham | 2026-08-15 |
| A Phase I/II Study of Eque-cel in Subjects Withimmune-mediated Necrotizing Myopathy (NCT07752264) | Nanjing IASO Biotechnology Co., Ltd. | 2026-08-15 |
| Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors (NCT07647068) | Joal Beane | 2026-08-15 |
| N-AD: Orally Administered Nicotinamide Riboside Over Two Years as a Potential Disease Modifying Treatment for Alzheimer's Disease (NCT07741071) | Haukeland University Hospital | 2026-08-15 |
| Phase II Clinical Study of VC005 Tablets in Subjects With Severe Alopecia Areata (NCT07749716) | Jiangsu vcare pharmaceutical technology co., LTD | 2026-08-15 |
| Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder (NCT07296094) | Brigham and Women's Hospital | 2026-08-15 |
| CEUS Evaluation of Hydrocephalus in Neonates and Infants (NCT06693752) | Children's Hospital of Philadelphia | 2026-08-15 |
| A Pan-RAS Inhibitor in Combination With Anti-Tumor Therapy in Participants With Advanced Pancreatic Cancer (NCT07736612) | Zhejiang University | 2026-08-15 |
| Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese (NCT06732245) | Biomed Industries, Inc. | 2026-08-15 |
| A Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma. (NCT07734116) | Ono Pharmaceutical Co., Ltd. | 2026-08-15 |
| A Study of Cladribine, Low Dose Cytarabine, and Venetoclax in Treatment of Relapsed/Refractory or Secondary Acute Myeloid Leukemia (NCT07423104) | University of Rochester | 2026-08-15 |
| Open-Label Neoadjuvant Pembrolizumab Plus Cetuximab in Betel Nut-Associated Locally Advanced Oral Cavity Squamous Cell Carcinoma (NCT07733466) | Peter Brett, MD | 2026-08-15 |
| Aging and Task-specific Training to Reduce Falls (NCT07094659) | University of Illinois at Chicago | 2026-08-15 |
| Rash & Diarrhea Prophylaxis With Capivasertib (NCT07426822) | Maryam Lustberg | 2026-08-15 |
| The Efficacy and Safety of HRS-4029 in Acute Ischemic Stroke Patients (NCT07739160) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2026-08-15 |
| Mirvetuximab Soravtansine Combined With Suvemcitug in Platinum-Resistant Recurrent Ovarian Cancer (NCT07741630) | Peking University Third Hospital | 2026-08-15 |
| A Open-Label Phase in Participants With Multiple Myeloma (NCT07764861) | Innovent Biologics (Suzhou) Co. Ltd. | 2026-08-15 |
| A Prospective, Single-Arm, Multicenter Clinical Study of High-Risk Localized and Locally Advanced Renal Clear Cell Carcinoma (NCT07741617) | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | 2026-08-15 |
| Photoimmunotherapy With ASP-1929 and Cemiplimab for the Treatment of Refractory, Inoperable, and Metastatic Stage IIIB-IV Non-small Cell Lung Cancer (NCT06943664) | Roswell Park Cancer Institute | 2026-08-15 |
| QL1706 Combined With Standard Therapy for Conversion Therapy of Synchronous Liver Metastases From Colon Cancer: a Multicenter, Single-arm, Exploratory Study (NCT07649473) | Fujian Medical University | 2026-08-15 |
| Testing the Addition of a New Anti-Cancer Drug, Glofitamab to Usual Chemotherapy for Burkitt and Double Hit Lymphoma (NCT07724457) | National Cancer Institute (NCI) | 2026-08-14 |
| Dietary Arginine Deprivation Combined With Chemoradiotherapy for Neoadjuvant Treatment of Rectal Cancer: A Randomized Controlled Trial (NCT07755124) | West China Hospital | 2026-08-14 |
| Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial (NCT07551596) | National Cancer Institute (NCI) | 2026-08-14 |
| TLL-018 in Patients With Moderate to Severe Active Rheumatoid Arthritis With Inadequate Response or Intolerance to csDMARDs (NCT07748728) | Hangzhou Highlightll Pharmaceutical Co., Ltd | 2026-08-14 |
| Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease Endotype (NCT07282210) | Biossil Inc. | 2026-08-13 |
| Mechanisms of Change in Behavioral Cough Suppression Therapy for Refractory Chronic Cough (NCT06960759) | University of Montana | 2026-08-13 |
| Respiratory and Real-time Dynamics in Exercise-Induced Paradoxical Vocal Fold Motion (NCT07420530) | Indiana University | 2026-08-12 |
| RP2 and Tivozanib for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy (NCT07218692) | City of Hope Medical Center | 2026-08-11 |
| Evaluation of Intra-articular CX-011 to Treat Moderate to Severe Pain From Knee Osteoarthritis (NCT07308834) | CarthroniX, Inc. | 2026-08-11 |
| A Study of Cyclophosphamide, Methotrexate, Fluorouracil (CMF) for People With Breast Cancer (NCT07768436) | Memorial Sloan Kettering Cancer Center | 2026-08-11 |
| Safety and Efficacy of Roflumilast Foam 0.3% in Adolescent and Adult Subjects With Hidradenitis Suppurativa (NCT07689188) | Harrison Dermatology | 2026-08-10 |
| STUPP Regimen With or Without Lenvatinib for Newly Diagnosed Glioblastoma With MGMT Promoter Methylation (NCT07754734) | Dongguan People's Hospital | 2026-08-10 |
| Pre-emptive Insulin to Prevent High Glucose After a Knee Steroid Injection in Adults With Type 2 Diabetes (NCT07757464) | Shifa International Hospital | 2026-08-10 |
| Short-Course RT Plus CAPOX and Tislelizumab vs Long-Course CRT Plus Tislelizumab for Locally Advanced Rectal Cancer (NCT07469306) | Fujian Cancer Hospital | 2026-08-10 |
| " Study of the Benefit of Nebulized Amikacin in the Treatment of Gram-negative Bacillus Pneumonia Acquired During Mechanical Ventilation in Patients Receiving Extracorporeal Membrane Veno-arterial Oxygenation " (NCT06602557) | Assistance Publique - Hôpitaux de Paris | 2026-08-10 |
| MRG003 Plus Toripalimab Versus Toripalimab as Neoadjuvant Therapy for PD-L1-Positive, Resectable, Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT07677475) | Dongguan People's Hospital | 2026-08-10 |
| NORTHERA (DROXIDOPA) for Dysautonomia in Pediatric Survivors of Menkes Disease (NCT07398508) | Stephen G. Kaler | 2026-08-10 |
| Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial (NCT07734792) | yifang zhu | 2026-08-10 |
| Phase II Clinical Study on the Efficacy and Safety of QLS7305 in Patients With Kidney Disease (Part A) (NCT07730632) | Qilu Pharmaceutical Co., Ltd. | 2026-08-10 |
| Navigation Bronchoscopy Guided Microwave Ablation Versus SBRT in Early NSCLC (NCT07722182) | Chinese University of Hong Kong | 2026-08-10 |
| Precision Integrated Strategies and Efficacy Evaluation for Biliary Tract Cancers: An Umbrella Platform Study (NCT07729917) | Zhejiang University | 2026-08-10 |
| Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer (NCT07147231) | National Cancer Institute (NCI) | 2026-08-10 |
| Assessment of a New Enhanced Xenograft in Open Maxillary Sinus Augmentation (NCT07737704) | Misr International University | 2026-08-10 |
| Evaluate the Effectiveness and Safety of BBD-1 Multi-target Immune Enhancement Targeting Agent in the Treatment of Hypersensitivity Reaction (IgA) Vasculitis (NCT07595367) | Qifeng Zhang | 2026-08-10 |
| A Study to Evaluate the Efficacy and Safety of AK139 in Participants With Chronic Rhinosinusitis With Nasal Polyps (NCT07755371) | Akeso | 2026-08-10 |
| Platform Trial in Stage 1 Diabetes: Comparing Golimumab vs Placebo (NCT07683026) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2026-08-08 |
| A Trial Evaluating Safety, Tolerability and Efficacy of CTX340 in Participants With Hypertension (NCT07758634) | CRISPR Therapeutics AG | 2026-08-08 |